Golam KhandakarClinician
Professor of psychiatry and immunology at Bristol medical school, investigator at the MRC integrative epidemiology unit at the university
Cited in UK press coverage of health & social care
1 citation
Across 1 topic, first on 27 Aug 2026.
Expertise
Cited on
What they’ve said
“This is one of the first randomised controlled trials to test immunotherapy for depression, the first to test IL-6R as the treatment target, and the first to use a targeted approach to select patients most likely to benefit, and to show that it works.”
Professor of psychiatry and immunology at Bristol medical school, investigator at the MRC integrative epidemiology unit at the university · Mental health · 27 Aug 2026 · Immunotherapy could be used to treat depression, early trial suggests ↗
Source references
- Immunotherapy could be used to treat depression, early trial suggeststheguardian.com · 27 Aug 2026
Doctors, nurses, allied health professionals and other registered clinicians quoted in a clinical capacity. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.